Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund | ETW | Nov 26, 2024 | 8.47 | +0.24 |
Eaton Vance Tax-Managed Global Diversified Equity Income Fun | EXG | Nov 26, 2024 | 8.34 | -0.12 |
Eaton Vance Taxmanaged Buywrite Income Fund | ETB | Nov 26, 2024 | 14.94 | +0.20 |
Ebang International A | EBON | Nov 26, 2024 | 7.29 | -8.88 |
eBay | EBAY | Nov 26, 2024 | 65.09 | +0.15 |
Ecarx A | ECX | Nov 26, 2024 | 1.88 | +4.44 |
ECB Bank | ECBK | Nov 26, 2024 | 14.90 | +0.88 |
ECD Automotive Design | ECDA | Nov 26, 2024 | 0.98 | +3.15 |
EchoStar | SATS | Nov 26, 2024 | 24.87 | +1.88 |
Eco Wave Power Global ADR | WAVE | Nov 26, 2024 | 11.61 | +0.35 |
EcoLab | ECL | Nov 26, 2024 | 247.38 | +0.19 |
Ecopetrol ADR | EC | Nov 26, 2024 | 7.98 | -1.48 |
Ecovyst | ECVT | Nov 26, 2024 | 8.00 | -1.72 |
EDAP TMS ADR | EDAP | Nov 26, 2024 | 2.37 | -4.05 |
Edesa Biotech | EDSA | Nov 26, 2024 | 2.21 | +2.79 |
Edgewell Personal Care | EPC | Nov 26, 2024 | 36.97 | +0.63 |
Edgewise Therapeutics | EWTX | Nov 26, 2024 | 32.08 | +0.31 |
Edgio | EGIO | Nov 26, 2024 | 1.38 | 0.00 |
Edible Garden | EDBL | Nov 26, 2024 | 0.16 | +2.75 |
Edison International | EIX | Nov 26, 2024 | 87.74 | +0.15 |
Editas Medicine | EDIT | Nov 26, 2024 | 2.21 | -7.14 |
Educational Development | EDUC | Nov 26, 2024 | 1.87 | -2.60 |
Edwards Lifesciences | EW | Nov 26, 2024 | 71.55 | +0.39 |
eFFECTOR Therapeutics | EFTR | Nov 26, 2024 | 0.18 | 0.00 |
eGain | EGAN | Nov 26, 2024 | 5.24 | -1.87 |
EHang ADR | EH | Nov 26, 2024 | 14.64 | -4.00 |
eHealth | EHTH | Nov 26, 2024 | 5.37 | -1.47 |
Eightco | OCTO | Nov 26, 2024 | 1.80 | -2.70 |
Ekso Bionics | EKSO | Nov 26, 2024 | 0.67 | -2.65 |
El Paso Pref | EP-C | Nov 26, 2024 | 48.25 | -0.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.